Fragment-based drug design (FBDD) has led to a revolution in contemporary drug discovery, facilitating a bottom-up approach to the identification and evolution of bioactive small molecules into viable ...
Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN: FR001400CM63; Ticker symbol: ALOPM), a biopharmaceutical company specializing in precision medicine for the treatment of resistant and ...
Developing new pharmaceuticals is a complex and costly process that requires innovation and efficiency. High-throughput immunoassays (HTIs) are an emerging technology poised to accelerate the drug ...
The Echo® MS+ system unlocks enhanced high-throughput screening capability by bringing acoustic ejection mass spectrometry (AEMS) approaches to the SCIEX ZenoTOF 7600 system. FRAMINGHAM, ...
Explore the impact of drug discovery automation in 2026, addressing complexity and improving decision-making across ...
Physiochemical properties such as solubility and dissolution rate play a crucial role when it comes to the therapeutic efficacy of oral drug formulations. According to the Biopharmaceutical ...
The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback